Susan G. Komen® Invests in the Future of Breast Cancer Research

Following through on a commitment to young scientists and clinicians, the Susan G. Komen® organization today announced new grants to more than 50 early-career breast cancer researc

Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign

Breast cancer is the second-most commonly diagnosed cancer, and a disease that touches us all.  Devoted to the mission to defeat breast cancer through education and medical research and currently active in more than 70 countries, The BCA Campaign has raised more than $53 million to support global research, education and medical services, with nearly $42 million funding 166 Breast Cancer Research …

Help bring us closer to a world without breast cancer

Breast cancer is the second-most commonly diagnosed cancer, and a disease that touches us all. The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign was courageously and boldly launched in 1992 by Mrs. Evelyn H. Lauder with the creation of the Pink Ribbon, the universal symbol for breast health. Devoted to the mission to defeat breast cancer through education and medical research …

Targeted treatment could halt womb cancer growth

( Cancer Research UK ) A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer.

Cancer gene test 'would save lives'

Younger bowel cancer patients should be offered a genetic test to screen for a rare condition linked to a higher risk of cancer, say UK researchers.

New Non-invasive Colon Cancer Test Claims 94% Accuracy

According to the World Cancer Research Fund and the American Institute for Cancer Research, colorectal cancer is the third most common cancer worldwide and the fourth most common cause of death for both men and women. Survivability rises if it is diagnosed early enough. A new type of test promises to replace the dreaded colonoscopy as the most reliable method for doing that. Doctors say the most …